YHB Investment Advisors Inc. Acquires 203 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

YHB Investment Advisors Inc. boosted its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 0.7% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 30,824 shares of the healthcare conglomerate’s stock after acquiring an additional 203 shares during the period. UnitedHealth Group accounts for 1.5% of YHB Investment Advisors Inc.’s holdings, making the stock its 15th biggest position. YHB Investment Advisors Inc.’s holdings in UnitedHealth Group were worth $18,022,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Kathleen S. Wright Associates Inc. acquired a new position in UnitedHealth Group in the 3rd quarter valued at $27,000. Macroview Investment Management LLC grew its holdings in UnitedHealth Group by 671.4% in the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock valued at $28,000 after buying an additional 47 shares in the last quarter. Delos Wealth Advisors LLC grew its holdings in shares of UnitedHealth Group by 757.1% during the 1st quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock worth $30,000 after purchasing an additional 53 shares in the last quarter. Bbjs Financial Advisors LLC acquired a new stake in shares of UnitedHealth Group during the 2nd quarter worth $31,000. Finally, Global Wealth Strategies & Associates grew its holdings in shares of UnitedHealth Group by 152.4% during the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after purchasing an additional 32 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several analysts have recently issued reports on UNH shares. TD Cowen increased their target price on UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a report on Friday, October 18th. KeyCorp initiated coverage on UnitedHealth Group in a research note on Friday, October 11th. They issued an “overweight” rating and a $675.00 price objective on the stock. Wells Fargo & Company raised their price objective on UnitedHealth Group from $525.00 to $630.00 and gave the company an “overweight” rating in a research note on Wednesday, July 17th. Stephens reduced their price objective on UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating on the stock in a research note on Wednesday, October 16th. Finally, UBS Group reduced their price objective on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a research note on Wednesday, October 16th. Four investment analysts have rated the stock with a hold rating, seventeen have issued a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $615.53.

UnitedHealth Group Price Performance

Shares of UNH opened at $564.48 on Thursday. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $608.63. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.88. The company has a market capitalization of $521.25 billion, a price-to-earnings ratio of 36.77, a price-to-earnings-growth ratio of 1.67 and a beta of 0.58. The business has a 50-day moving average of $584.16 and a 200-day moving average of $536.49.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, topping the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The business had revenue of $100.82 billion during the quarter, compared to analysts’ expectations of $99.14 billion. During the same quarter last year, the firm posted $6.56 earnings per share. The firm’s revenue was up 9.2% on a year-over-year basis. As a group, equities research analysts anticipate that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th were paid a $2.10 dividend. The ex-dividend date was Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a yield of 1.49%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.72%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.